Company: IXHL
Filing Date: 2025-04-07
Form Type: 424B5
Source: 0001213900-25-029414
Chunk: 30

Company: Incannex Healthcare Inc.
Filing Date: 2025-04-07
Form: 424B5
Chunk 30
---
.P. and/or its affiliates
have in the past engaged, and may in the future engage, in transactions with, and may perform, from time to time, investment banking and
advisory services for us in the ordinary course of their business and for which it would receive customary fees and expenses. In addition,
in the ordinary course of its business activities, A.G.P. and its affiliates may make or hold a broad array of investments and actively
trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for its own account
and for the accounts of its customers. Such investments and securities activities may involve securities and/or instruments of ours or
our affiliates.

In March 2025, we completed
the Private Placement. In connection therewith, we entered into an engagement letter with A.G.P. pursuant to which we agreed to pay a
cash fee (the “Cash Fee”) equal to 7.00% of the aggregate purchase price actually paid by each purchaser of securities not
listed on Exhibit A therein at the closing of the Private Placement. Notwithstanding the forgoing and in connection with purchases of
securities in the Private Placement by persons and/or entities for which fees were already payable in accordance with the terms of that
certain Engagement Letter, dated March 4, 2024, by and between the Company and JonesTrading Institutional Services LLC (“JonesTrading”)
as amended by that certain Amendment and Supplement, dated November 12, 2024, by and between the Company and JonesTrading, the Cash Fee
payable will instead be equal to 3.5% of the aggregate purchase price actually paid at the closing of the Private Placement. Per the terms
of our agreements with JonesTrading, we will also be obligated to pay 3.5% of gross proceeds raised from certain persons and entities
if such persons and entities purchase shares in connection with the Sales Agreement.

<div align='center'>S-15

LEGAL
MATTERS</div>

The validity of the common
stock offered by this prospectus supplement has been passed upon for us by Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., San Diego,
California. Thompson Hine LLP, New York, New York, is acting as counsel for A.G.P.

<div align='center'>EXPERTS</div>

The consolidated financial
statements incorporated by reference herein and in the registration statement have been so incorporated by reference in reliance upon